Clinical Trials Directory

Trials / Terminated

TerminatedNCT01050244

The Effect of Soy Protein on Neuropathic Pain

The Effect of Soy Protein on Neuropathic Pain: Randomized N-of-1 Trials

Status
Terminated
Phase
Phase 2
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Dr. Yoram Shir · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Neuropathic pain is one form of chronic pain lacking effective pharmacotherapy. Interest in the role of complementary and alternative medicine is growing and diet is at the forefront of the search for alternative treatments for pain. Soy protein is one of the most promising dietary ingredients tested for its pain-relieving properties. Results from animal studies show that soy-enriched diets reduce pain due to nerve injury. The purpose of this study is to determine the effects of soy protein supplementation on facial pain.

Detailed description

Neuropathic pain is a complex disorder with mixed results in response to pain medication due to a high degree of variability between patients. To address this issue, we are implementing a unique methodology using a series of N-of-1 or single subject randomized, double blind, controlled studies. With this, we will explore the role of soy protein supplementation in neuropathic pain patients. Each patient will be exposed in 3-week intervals to soy protein and a control, milk protein, in three paired treatment periods for a total of 18 weeks. This method allows for the measurement of treatment efficacy in individual distinct patients and has the potential for immediate and continued medical benefit using a simple and readily available dietary ingredient.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTWhole soybean soymilk powder
DIETARY_SUPPLEMENTWhole milk powder

Timeline

Start date
2011-02-01
Primary completion
2015-11-01
Completion
2015-11-01
First posted
2010-01-15
Last updated
2016-03-22

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01050244. Inclusion in this directory is not an endorsement.